Enterprise Clinical Intelligence

The Future of Healthcare Decision Intelligence

A probabilistic map of real-world medicine. A specialist performance ranking system. And a decision-outcome engine — built on the world's largest structured advisory dataset.

180+

Countries Covered

42K+

Verified Physicians

50K+

Clinical Opinions

98%

Enterprise Satisfaction

Strategic Vision

This Is Not Telemedicine.
This Is A Clinical Intelligence Infrastructure.

A probabilistic map of real-world medicine, A doctor performance ranking system and A decision-outcome engine. 

The Compounding Intelligence Flywheel

Case Submitted

Structured intake

AI Analyzes

Differential + confidence

Specialist Reviews

Structured opinion

Outcome Tracked

Closes the loop

Dataset Grows

Intelligence compounds

More cases → better data → smarter AI → better outcomes → more trust → more cases

Three Intelligence Products. One Dataset.

Probabilistic Disease Map

Real-time diagnostic probability distributions across conditions, geographies, and demographics. Updated continuously from live case data.

Specialist Performance Index

The first outcome-linked physician ranking system. Diagnostic accuracy, guideline adherence, and patient outcomes — not just star ratings.

Decision-Outcome Engine

Which diagnostic decisions lead to which outcomes? The full decision tree — from first symptom to final outcome — across thousands of real cases.

Projected Enterprise Customers

Health Insurers

Reduce unnecessary procedures

Independent second opinions before high-cost procedures. Outcome-linked data to identify overtreatment patterns.

30%

of procedures are clinically unnecessary

Hospitals & Health Systems

Clinical decision support layer

AI-structured case analysis + global specialist opinions on complex cases. Reduce diagnostic error. Build your proprietary outcome dataset.

87%

of second opinions change the diagnosis

Pharma & Life Sciences

Real-world evidence at scale

Outcome-linked, specialty-tagged, AI-normalized clinical data. Diagnostic patterns, treatment pathways, and trial recruitment targeting.

62%

of FDA approvals now require RWE

For insurers · hospitals · pharma · life sciences